Correlation Between Aerovate Therapeutics and Aura Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Aura Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Aura Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Aura Biosciences, you can compare the effects of market volatilities on Aerovate Therapeutics and Aura Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Aura Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Aura Biosciences.

Diversification Opportunities for Aerovate Therapeutics and Aura Biosciences

0.52
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Aerovate and Aura is 0.52. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Aura Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aura Biosciences and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Aura Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aura Biosciences has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Aura Biosciences go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Aura Biosciences

Given the investment horizon of 90 days Aerovate Therapeutics is expected to generate 1.58 times more return on investment than Aura Biosciences. However, Aerovate Therapeutics is 1.58 times more volatile than Aura Biosciences. It trades about 0.23 of its potential returns per unit of risk. Aura Biosciences is currently generating about -0.32 per unit of risk. If you would invest  218.00  in Aerovate Therapeutics on August 29, 2024 and sell it today you would earn a total of  50.00  from holding Aerovate Therapeutics or generate 22.94% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Aerovate Therapeutics  vs.  Aura Biosciences

 Performance 
       Timeline  
Aerovate Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Aerovate Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Aerovate Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.
Aura Biosciences 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Aura Biosciences are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Aura Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.

Aerovate Therapeutics and Aura Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Aerovate Therapeutics and Aura Biosciences

The main advantage of trading using opposite Aerovate Therapeutics and Aura Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Aura Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aura Biosciences will offset losses from the drop in Aura Biosciences' long position.
The idea behind Aerovate Therapeutics and Aura Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account